46 related articles for article (PubMed ID: 33227442)
1. Target tailoring and proton beam therapy to reduce small bowel dose in cervical cancer radiotherapy : A comparison of benefits.
de Boer P; van de Schoot AJAJ; Westerveld H; Smit M; Buist MR; Bel A; Rasch CRN; Stalpers LJA
Strahlenther Onkol; 2018 Mar; 194(3):255-263. PubMed ID: 29101415
[TBL] [Abstract][Full Text] [Related]
2. Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear.
Yen A; Zhong X; Lin MH; Nwachukwu C; Albuquerque K; Hrycushko B
Clin Oncol (R Coll Radiol); 2024 Mar; 36(3):165-172. PubMed ID: 38246849
[TBL] [Abstract][Full Text] [Related]
3. Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
Zeng Z; Zhu J; Wang Z; Wang G; Yan J; Zhang F
Radiat Oncol; 2024 Apr; 19(1):48. PubMed ID: 38622628
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.
Dinges E; Felderman N; McGuire S; Gross B; Bhatia S; Mott S; Buatti J; Wang D
Radiother Oncol; 2015 Jun; 115(3):373-8. PubMed ID: 25981130
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.
Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P
BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111
[TBL] [Abstract][Full Text] [Related]
6. ROAR-A: re-optimization based Online Adaptive Radiotherapy of anal cancer, a prospective phase II trial protocol.
Storm KS; Åström LM; Sibolt P; Behrens CP; Persson GF; Serup-Hansen E
BMC Cancer; 2024 Mar; 24(1):374. PubMed ID: 38528456
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the impact of different levels of inspiratory volume using active breathing control on the intrafraction motion and dose coverage of target volumes in patients undergoing thoracic radiotherapy.
Hui MCM; Chiu G; Wong S; Lien SL
J Med Imaging Radiat Sci; 2023 Dec; 54(4):653-661. PubMed ID: 37620180
[TBL] [Abstract][Full Text] [Related]
8. Treatment planning evaluation and experimental validation of the magnetic resonance-based intrafraction drift correction.
van den Dobbelsteen M; Hackett SL; van Asselen B; Oolbekkink S; Raaymakers BW; de Boer JCJ
Phys Imaging Radiat Oncol; 2024 Apr; 30():100580. PubMed ID: 38707627
[TBL] [Abstract][Full Text] [Related]
9. Real-Time Gated Proton Therapy: Commissioning and Clinical Workflow for the Hitachi System.
Chen H; Gogineni E; Cao Y; Wong J; Deville C; Li H
Int J Part Ther; 2024 Mar; 11():100001. PubMed ID: 38757076
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy delivery: what is needed in the next ten years?
Schreuder AN; Shamblin J
Br J Radiol; 2020 Mar; 93(1107):20190359. PubMed ID: 31692372
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?
Alexander SE; Oelfke U; Westley R; McNair HA; Tree AC
Clin Transl Radiat Oncol; 2023 Nov; 43():100685. PubMed ID: 37842073
[TBL] [Abstract][Full Text] [Related]
12. Uncertainties in ocular proton planning and their impact on required margins.
Wulff J; Koska B; Ahmad Khalil D; Richter R; Maximilian Bäcker C; Bäumer C; Foerster A; Bechrakis NE; Timmermann B
Phys Med; 2024 May; 121():103358. PubMed ID: 38643558
[TBL] [Abstract][Full Text] [Related]
13. Delineating the inner bladder surface using uniform contractions from the outer surface under variable bladder filling conditions.
Rosewall T; Bayley A; Catton C; Chung P; Currie G; Heaton R; Wheat J; Milosevic M
Br J Radiol; 2015 Sep; 88(1053):20140818. PubMed ID: 26206519
[TBL] [Abstract][Full Text] [Related]
14. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
[TBL] [Abstract][Full Text] [Related]
15. Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer.
Khouya A; Pöttgen C; Hoffmann C; Ringbaek TP; Lübcke W; Indenkämpen F; Guberina M; Guberina N; Gauler T; Stuschke M; Santiago Garcia A
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067333
[TBL] [Abstract][Full Text] [Related]
16. A survey of practice patterns for adaptive particle therapy for interfractional changes.
Trnkova P; Zhang Y; Toshito T; Heijmen B; Richter C; Aznar MC; Albertini F; Bolsi A; Daartz J; Knopf AC; Bertholet J
Phys Imaging Radiat Oncol; 2023 Apr; 26():100442. PubMed ID: 37197154
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric Impact of Intrafraction Motion in Online-Adaptive Intensity Modulated Proton Therapy for Cervical Cancer.
Berger T; Godart J; Jagt T; Vittrup AS; Fokdal LU; Lindegaard JC; Kibsgaard Jensen NB; Zolnay A; Reijtenbagh D; Trnkova P; Tanderup K; Hoogeman M
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1580-1587. PubMed ID: 33227442
[TBL] [Abstract][Full Text] [Related]
18. Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans.
Bondar ML; Hoogeman MS; Mens JW; Quint S; Ahmad R; Dhawtal G; Heijmen BJ
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1617-23. PubMed ID: 22270164
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes.
Visser J; de Boer P; Crama KF; van Kesteren Z; Rasch CRN; Stalpers LJA; Bel A
Radiat Oncol; 2019 Jul; 14(1):126. PubMed ID: 31300000
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
